CHMP meeting highlights – January 2025
In its January meeting, the EMA’s human medicines committee recommended eight new medicines, including biosimilars and a new vaccine.
List view / Grid view
In its January meeting, the EMA’s human medicines committee recommended eight new medicines, including biosimilars and a new vaccine.
Sandoz intends to seek regulatory approval for its aflibercept biosimilar in the US and EU in the coming months.